These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13801)

  • 1. Effect of altered lymphocyte function on immunologic disorders in NZB/NZW mice.
    Mehta J; Knotts LL; Hahn BH
    Arthritis Rheum; 1977; 20(1):65-72. PubMed ID: 13801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.
    Hahn BH; Ebling FM
    J Clin Invest; 1983 Jun; 71(6):1728-36. PubMed ID: 6223048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of altered lymphocyte function on the immunologic disorders of NZB/NZW mice. Response to anti-thymocyte globulin.
    Hahn BH; Mehta J; Knotts LL; Ihle JN; Levy JA
    Clin Immunol Immunopathol; 1977 Sep; 8(2):225-37. PubMed ID: 71225
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteration of lymphocyte function in NZB/NZW mice. IV. Response to levamisole.
    Hahn BH; Knotts LL
    Arthritis Rheum; 1979 Mar; 22(3):236-42. PubMed ID: 33681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of NZB/W F1 mice with NZW splenic T cells or with serum of mice experiencing the graft-versus-host reaction: suppression of ongoing anti-double-stranded (ds) DNA antibody formation and improvement of renal function.
    Okudaira H; Terada E; Fukuda K; Ito T; Gohda A; Nomura T; Kudo K; Ogita T; Miyamoto T
    Clin Immunol Immunopathol; 1984 Sep; 32(3):359-67. PubMed ID: 6331933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse.
    Werwitzke S; Trick D; Kamino K; Matthias T; Kniesch K; Schlegelberger B; Schmidt RE; Witte T
    Arthritis Rheum; 2005 Nov; 52(11):3629-38. PubMed ID: 16255055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids.
    al-Balaghi S; Möller E; Möller G; Abedi-Valugerdi M
    Eur J Immunol; 1996 Jul; 26(7):1519-26. PubMed ID: 8766555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
    Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
    J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
    Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD
    Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA.
    Hahn BH; Ebling FM
    J Immunol; 1984 Jan; 132(1):187-90. PubMed ID: 6606665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
    Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
    Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of lupus nephritis in adult (NZB + NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens.
    Borel Y; Lewis RM; André-Schwartz J; Stollar BD; Diener E
    J Clin Invest; 1978 Feb; 61(2):276-86. PubMed ID: 304453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of suppressor T cells in adult NZB/NZW mice.
    Krakauer RS; Waldmann TA; Strober W
    J Exp Med; 1976 Sep; 144(3):662-73. PubMed ID: 1085336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models utilized in the research of autoimmune disease control: experimental therapy of glomerulonephritis in NZB/W F1 mice.
    Okudaira H; Terada E; Okudaira K
    Prog Clin Biol Res; 1987; 229():157-74. PubMed ID: 3601985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.